DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

2.14 -0.04 (-1.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RIGL $2.14 -1.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.15
Previous Close $2.18
Daily Range $2.09 - $2.17
52-Week Range $2.03 - $5.00
Market Cap $187.9M
P/E Ratio -2.16
Dividend (Yield) $0.00 (0.0%)
Volume 703,925
Average Daily Volume 644,471
Current FY EPS -$1.12

Sector

Healthcare

Industry

Drugs

Rigel Pharmaceuticals, Inc. (RIGL) Description

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Website: http://www.rigel.com/

News & Commentary

Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc

The S&P 500 dips for a second-straight day following weak economic data while VAALCO Energy, Rigel, and Companhia Siderurgica Nacional shares surge by double-digits.

What You Need to Know About the Roche-InterMune Deal

InterMune's Roche Deal Sends Peer Group Up

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog

Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial

Sector Update: Health Care

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog

Rigel Initiates Phase 3 Studies Of Fostamatinib In ITP

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

See More RIGL News...

RIGL's Top Competitors

RIGL $2.14 (-1.83%)
Current stock: RIGL
GILD $105.47 (-0.46%)
Current stock: GILD
AMGN $142.18 (-1.27%)
Current stock: AMGN
BIIB $329.76 (0.16%)
Current stock: BIIB